PFIZER Quarterly Results
| Standalone | Dec2025 UnAudited |
Sep2025 UnAudited |
Jun2025 UnAudited |
Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
|---|---|---|---|---|---|---|---|---|
| Revenues | ₹645 Cr | ₹642 Cr | ₹603 Cr | ₹592 Cr | ₹538 Cr | ₹589 Cr | ₹563 Cr | ₹547 Cr |
| Expenses | ₹417 Cr | ₹412 Cr | ₹393 Cr | ₹364 Cr | ₹392 Cr | ₹399 Cr | ₹385 Cr | ₹357 Cr |
| Operating Income | ₹228 Cr | ₹230 Cr | ₹210 Cr | ₹228 Cr | ₹146 Cr | ₹189 Cr | ₹177 Cr | ₹189 Cr |
| Other Income | ₹38 Cr | ₹42 Cr | ₹67 Cr | ₹45 Cr | ₹43 Cr | ₹43 Cr | ₹42 Cr | ₹75 Cr |
| Interest | ₹2 Cr | ₹2 Cr | ₹3 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹7 Cr |
| Depreciation | ₹14 Cr | ₹14 Cr | ₹14 Cr | ₹16 Cr | ₹15 Cr | ₹15 Cr | ₹15 Cr | ₹14 Cr |
| Profit Before Tax | ₹192 Cr | ₹255 Cr | ₹260 Cr | ₹426 Cr | ₹172 Cr | ₹215 Cr | ₹203 Cr | ₹244 Cr |
| Profit After Tax | ₹142 Cr | ₹189 Cr | ₹192 Cr | ₹331 Cr | ₹128 Cr | ₹158 Cr | ₹151 Cr | ₹179 Cr |
| EPS | ₹31.00 | ₹41.32 | ₹41.91 | ₹72.34 | ₹27.89 | ₹34.61 | ₹32.94 | ₹39.10 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| PFIZER | -0.1% | 11.3% | 24.4% |
| SUN PHARMACEUTICAL INDUSTRIES | 0.3% | 9% | 8.6% |
| DIVIS LABORATORIES | 1.9% | 5.9% | 12.6% |
| CIPLA | 1.6% | 1.8% | -7.9% |
| TORRENT PHARMACEUTICALS | 0.6% | 9.5% | 45% |
| DR REDDYS LABORATORIES | -1.5% | 5.7% | 14.5% |
| MANKIND PHARMA | 9.9% | 5.8% | -2% |
| ZYDUS LIFESCIENCES | 1.6% | 4.2% | 6% |
| LUPIN | 2.5% | 7% | 21.9% |
PFIZER Quarterly Revenues
| Revenues | |
|---|---|
| Q-o-Q | 0.42 % |
| Y-o-Y | 19.90 % |
| Quarters | Revenues | % Change | |
|---|---|---|---|
| Dec2025 | ₹645 Cr | 0.42 | |
| Sep2025 | ₹642 Cr | 6.52 | |
| Jun2025 | ₹603 Cr | 1.88 | |
| Mar2025 | ₹592 Cr | 10.02 | |
| Dec2024 | ₹538 Cr | -8.60 | |
| Sep2024 | ₹589 Cr | 4.57 | |
| Jun2024 | ₹563 Cr | 2.97 | |
| Mar2024 | ₹547 Cr | - | |
PFIZER Quarterly Operating Profit
| Operating Profit | |
|---|---|
| Q-o-Q | -0.76 % |
| Y-o-Y | 56.31 % |
| Quarters | Operating Profit | % Change | |
|---|---|---|---|
| Dec2025 | ₹228 Cr | -0.76 | |
| Sep2025 | ₹230 Cr | 9.48 | |
| Jun2025 | ₹210 Cr | -7.68 | |
| Mar2025 | ₹228 Cr | 55.83 | |
| Dec2024 | ₹146 Cr | -22.86 | |
| Sep2024 | ₹189 Cr | 6.63 | |
| Jun2024 | ₹177 Cr | -6.30 | |
| Mar2024 | ₹189 Cr | - | |
| Operating Margins | |
|---|---|
| Q-o-Q | -1.17 % |
| Y-o-Y | 30.36 % |
| Quarters | Operating Margin% | % Change | |
|---|---|---|---|
| Dec2025 | 35.38% | -1.17 | |
| Sep2025 | 35.8% | 2.78 | |
| Jun2025 | 34.83% | -9.37 | |
| Mar2025 | 38.43% | 41.60 | |
| Dec2024 | 27.14% | -15.58 | |
| Sep2024 | 32.15% | 1.97 | |
| Jun2024 | 31.53% | -9.00 | |
| Mar2024 | 34.65% | - | |
PFIZER Quarterly Profit After Tax
| Profit After Tax(PAT) | |
|---|---|
| Q-o-Q | -24.96 % |
| Y-o-Y | 11.16 % |
| Quarters | Profit After Tax | % Change | |
|---|---|---|---|
| Dec2025 | ₹142 Cr | -24.96 | |
| Sep2025 | ₹189 Cr | -1.42 | |
| Jun2025 | ₹192 Cr | -42.06 | |
| Mar2025 | ₹331 Cr | 159.36 | |
| Dec2024 | ₹128 Cr | -19.42 | |
| Sep2024 | ₹158 Cr | 5.07 | |
| Jun2024 | ₹151 Cr | -15.74 | |
| Mar2024 | ₹179 Cr | - | |
| PAT Margins | |
|---|---|
| Q-o-Q | -25.28 % |
| Y-o-Y | -7.29 % |
| Quarters | PAT Margin(%) | % Change | |
|---|---|---|---|
| Dec2025 | 21.99 % | -25.28 | |
| Sep2025 | 29.43 % | -7.45 | |
| Jun2025 | 31.8 % | -43.12 | |
| Mar2025 | 55.91 % | 135.71 | |
| Dec2024 | 23.72 % | -11.82 | |
| Sep2024 | 26.9 % | 0.45 | |
| Jun2024 | 26.78 % | -18.15 | |
| Mar2024 | 32.72 % | - | |
PFIZER Quarterly Earnings Per Share (EPS)
| EPS | |
|---|---|
| Q-o-Q | -24.98 % |
| Y-o-Y | 11.15 % |
| Quarters | EPS | % Change | |
|---|---|---|---|
| Dec2025 | ₹31 | -24.98 | |
| Sep2025 | ₹41.32 | -1.41 | |
| Jun2025 | ₹41.91 | -42.07 | |
| Mar2025 | ₹72.34 | 159.38 | |
| Dec2024 | ₹27.89 | -19.42 | |
| Sep2024 | ₹34.61 | 5.07 | |
| Jun2024 | ₹32.94 | -15.75 | |
| Mar2024 | ₹39.1 | - | |
You may also like the below Video Courses